Breast cancer drug trastuzumab induces cardiac toxicity: evaluation of human epidermal growth factor receptor 2 as a potential diagnostic and prognostic marker
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions | SpringerLink
Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram
Herceptin® (trastuzumab) for HER2+ Cancer
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer | Oncotarget
Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology
Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer | Semantic Scholar
Trastuzumab: triumphs and tribulations | Oncogene
Trastuzumab (Herceptin) | American Journal of Neuroradiology
Herceptin: mechanisms of action and resistance - ScienceDirect
View Image
Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text
References in Evolving novel anti-HER2 strategies - The Lancet Oncology
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
4 Mechanisms of Action of Trastuzumab
Precision medicine and personalized breast cancer: combination pertuzu | PGPM
Resistance to Trastuzumab in Breast Cancer. - Abstract - Europe PMC
HERCEPTIN® Trastuzumab Albane Brunel, Claire d'Avout, Domitille Fernet, Nadia Taleb. - ppt download
IJMS | Free Full-Text | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | HTML
Pertuzumab: Development Beyond Breast Cancer | Anticancer Research
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer
